Quote:“We all know you’re not happy with your choices right now, but it’s getting near closing time and you’re gonna have to go home with one of them,” he added.
Unfair…to bar patrons and dead cats. LOL!
Bill Maher Explains To GOP Voters Why Hillary Clinton Is Their Only Hope. The comedian compared the bitterly divided party to “a filthy, pee-stained house full of dead cats.”
04/09/2016 03:45 am ET | Updated 2 hours ago
• Lee MoranTrends Editor, The Huffington Post
Bill Maher has a radical suggestion for Republicans: They should take a punt on Democratic presidential candidate Hillary Clinton this November.
The “Real Time with Bill Maher” host said on Friday night the GOP would lose the presidential elections under Donald Trump or Sen. Ted Cruz (R-Texas), so he advised Republican supporters to do themselves a favor and switch sides.
“Help put Hillary Clinton in the Oval Office and you’ll have her right where you want her,” he said. “I know it sounds crazy, but the only way you can win this November is by losing.”
Maher said many Republicans were already flirting with the idea of voting Democrat, rather than for either of the two leading GOP candidates.
“We all know you’re not happy with your choices right now, but it’s getting near closing time and you’re gonna have to go home with one of them,” he added.
Describing Cruz as “a man with all the appeal of Jared [Fogle] from Subway, minus the inspiring weight loss story” and Trump as the “zombie candidate,” Maher revealed there was actually a different option for disillusioned Republicans.
It would be perfect, given that Republicans didn’t actually want to — and probably couldn’t — govern due to the mess the party is currently in, he said. And it would mean they could probably scupper every bill that Clinton tries to pass.
“It’s like one of those houses where an old lady lived with 100 cats who peed everywhere,” Maher said of the GOP. “That is your party today — a filthy, pee-stained house full of dead cats.
“Do you really want to spend four years defending every single thing President Trump tweets in the middle of the night, defending every stupid thing he does, when he invades Poland or puts Hulk Hogan on the nickel or retweets our nuclear codes?”
Then take a punt and vote for Clinton, he said as he lightheartedly reminded Republicans that they “can’t impeach her” if they don’t elect her.
See you the 'Satanist' and raise you this: “We all
Top 10 Most Recent News Articles
Swanson Nexus Pro Launch: Boost for Dietitians
Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...
Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC
Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...
Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety
Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...
Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard
A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...
Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies
Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...
Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off
Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...
Continue ReadingTop 5 Most Recently Viewed Articles
Exploring Precious Metals and Energy Investors' Strategies
Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...
Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores
Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...
Continue Reading
China's New Lending Outlook: Economic Recovery Strategies
China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...
Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors
ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...
Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders
Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....
Continue Reading